Archive - September 2024
Fasenra Approved in the US for Eosinophilic Granulomatosis with Polyangiitis
Up to one-third of antibody drugs are nonspecific
UKRI’s MRC awards £27.4m to University of Dundee research unit
FDA Approves Kisqali to Reduce Risk of Recurrence in People with HR+/HER2- Early Breast Cancer
FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
Galderma: Account Manager – Midlands
WHO adds first mpox vaccine to prequalification list
More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050